NUTRITIONAL COMPOSITION FOR USE IN THERAPY OF PATIENTS WITH COPD, NEUROLOGICAL DISEASES OR DISORDERS AND/OR WOUNDS

• Main Authors: MAINOU-SIERRA, José, Maria, PESTANA, Ericka, MARTINEZ-BOCK, Maria, Fernanda, BRITO DE LA FUENTE, Edmundo, ASHLEY, Sarah, REICHART, Stephanie
• Format: Patent
• Language: English; French; German
• Published: 25.09.2019
• Subjects: FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of patients with COPD, neurological diseases or disorders and/or wounds, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN% based on the total energy of the nutritional composition, wherein 12-16 EN% based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100mL alpha-TE vitamin E, c) 5.0-12.0 µg/100mL vitamin D, d) 2.5-4.5 g/100mL glycine, e) 0.5-1.5 g/100mL arginine, and f) at least 0.02 g/100mL tryptophan.